| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |